Author Profile

Novartis Pledges $480M China Expansion
The drugmaker will build up its tablets/capsules and packaging plant in Changping, as well as expand its headquarters in Shanghai. read more
FDA Approves J&J Oral IL-23 Peptide for Plaque Psoriasis
Icotyde is the first and only IL-23R targeted oral peptide that delivers complete skin clearance and favorable safety profile in a once-daily pill. read more
FDA Warns of Seizure Risk from Merz’s Oral MS Med
The drug is approved for improving walking in MS patients but there is a risk of seizures for patients with renal impairment. read more
UMSL Receives $1M+ Federal Investment to Launch API Innovation Hub
The hub will manufacture APIs and finished drug products to strengthen the domestic supply chain. read more
Bayer Looks to Broaden Use of Kidney Disease Drug
Finerenone is already approved for chronic kidney disease associated with type 2 diabetes, but patients with non-diabetic CKD have few treatment options. read more
Structure Oral GLP-1 Boasts 16% Weight Loss in Trials
This is the highest efficacy of any oral GLP-1 to date, with a comparable efficacy to injectables. read more
The Constant Flow of Innovation
If history tells us anything, it’s this: in drug delivery, progress doesn’t come in bursts. It flows — steady, adaptable and always moving forward. read more
Evotec Unveils Layoffs, Site Closures
The company's global footprint will be further streamlined to 10 sites. read more
Xenon Trial Data Tees Up FDA Submission for New Epilepsy Drug
If approved, azetukalner would be the only KV7 potassium channel opener available for the treatment of epilepsy. read more
Liquid-Filled Capsules: From Niche to Mainstream
Liquid-filled capsules are no longer a specialized workaround but a technically sophisticated platform that demands deliberate alignment among formulation design, manufacturing capability and quality strategies. read more
BMS Shares Positive Phase 3 Results for Oral Mezigdomide in Multiple Myeloma
The trial data underscore the potential of MeziKd as an oral regimen that could address a key unmet need for patients who relapse. read more
Roche Oral SERD Fails in 1st-Line Breast Cancer Trial
Roche remains confident in giredestrant’s potential to become a new standard-of-care endocrine therapy in early and advanced ER-positive breast cancer. read more
Lonza to Sell Capsule & Health Ingredients Unit to Lone Star for $3B
Lonza will retain a 40% equity position in the business. read more
Sanofi Bets $1.53B on Sino Biopharm Oral JAK/ROCK Inhibitor
The drug is approved in China as treatment for myelofibrosis, but Sanofi wants to explore its potential to treat cGVHD. read more
FDA Grants Vanda Drug Approval Hearing for Sleep Drug
Following a successful court case against the FDA, Vanda is seeking to expand Hetlioz' approval to jet lag. read more
Digital, Continuous and Data-Rich
Advances in technologies, data, and development strategies are reshaping how oral solid dosage drugs are designed and manufactured, with a clear emphasis on lowering cost, shortening timelines, and improving quality and ... read more
Aardvark Pauses Prader-Willi Trials in Wake of Cardiac Concerns
The company observed reversible cardiac issues in healthy volunteers who were taking above target therapeutic doses. read more
Novo Nordisk to Invest $510M in Ireland Tableting Facility for Oral GLP-1s
The company will use the investment to turn Ireland into a hub for producing high-quality oral medications to distribute outside the U.S. read more
Merck Releases Data from Phase 3 Trials for HIV Drug Regimen
If approved, DOR/ISL may provide an important new option to help meet the evolving treatment needs of people living with HIV. read more
Genentech Releases Positive Phase 3 Data for Oral BTK Inhibitor
Results are comparable to another phase 3 trial, solidifying the oral drug’s potential to become the first BTK inhibitor for relapsing multiple sclerosis. read more

January/February 2026

2026 Annual Buyer’s Guide
View Issue

Subscribe to Magazine

Get started here for your complimentary print or digital subscription

Get started here for your complimentary print or digital subscription
Sign up Now »

Keep up with our latest articles, news and events. Plus, get special offers and more delivered to your inbox!